Editorial: Give FDA post-approval oversight authority

The Washington Post called for giving the FDA greater authority to oversee drugs after they have been approved and reach the market. An editorial urged the House to pass a Senate-approved bill that would require the agency to order post-approval studies if there is even a chance of risk involved with a drug.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA